1 Followers on Owler
DIACCURATE is a France-based biotechnology firm that researches and commercializes novel drugs for the treatment of cancers and orphan diseases... Read more
OverviewAcquisitionsNews & Insights
DIACCURATE is a France-based biotechnology firm that researches and commercializes novel drugs for the treatment of cancers and orphan diseases... Read more
Evexta Bio CEO: Scott Filosi

CEO

Scott Filosi

CEO Approval Rating

- -/100

2014

Private

Pharmaceuticals & Biotechnology
Biotechnology

Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Acquisitions
1

News

Partnership
Aug 05, 2026
Pharmabiz
Evexta Bio enters clinical trial collaboration and supply agreement with Roche to evaluate rupitasertib in combo with a SERD in advanced/metastatic breast cancer

Trending Companies